NCT00825045 Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia Status UNKNOWN Phase NA
NCT00823199 An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia Status COMPLETED Phase NA
NCT00821600 Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia Status COMPLETED Phase PHASE1
NCT00818298 24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study Status COMPLETED Phase NA
NCT00817648 A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00817154 Individually Based Psychosocial Rehabilitation for Older People With Serious Mental Illness (SMI) Status COMPLETED Phase PHASE1
NCT00816907 The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study) Status COMPLETED Phase PHASE4
NCT00815854 Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects Status COMPLETED Phase NA
NCT00813436 The Effect of Intranasal Administration of Oxytocin on Empathic Abilities. Status UNKNOWN Phase PHASE2
NCT00810667 Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With Schizophrenia Status COMPLETED Phase PHASE2
NCT00809770 Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill Status COMPLETED Phase NA
NCT00809731 Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment Status COMPLETED Phase N/A
NCT00805454 Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712 Status COMPLETED Phase PHASE1
NCT00802919 Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors Status COMPLETED Phase PHASE4
NCT00802100 Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia Status COMPLETED Phase PHASE4